Diamines & Chemicals Halts Insider Trading Ahead of FY26 Results

Diamines & Chemicals Ltd reported a consolidated net loss of ₹340.31 crore for the third quarter of FY26, with revenue from operations falling to ₹763.87 crore during the same period.

Trading Window Closure Announced

The company announced the closure of its trading window for designated persons, effective April 1, 2026. This measure aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will remain shut until 48 hours after the declaration of its audited financial results for the fiscal year ending March 31, 2026.

Purpose of Trading Window Closure

Trading window closures are a standard regulatory practice. They prevent the misuse of unpublished price-sensitive information (UPSI) by company insiders. This restriction helps ensure fair trading practices and maintains market integrity, especially before financial results are released.

Company and Financial Context

Diamines & Chemicals manufactures ethylene amines and operates in the specialty chemicals sector, supplying industries like pharmaceuticals and agrochemicals. However, the company has faced significant financial challenges recently. Its net sales have shown a negative compound annual growth rate (CAGR) of -5.94% over the past five years, and its operating profit has fallen sharply by -198.21%. The company's board has also recently met to consider converting warrants into equity shares, indicating ongoing capital restructuring efforts.

Impact on Insiders

Consequently, designated persons, their immediate relatives, and connected persons are now prohibited from trading in the company's securities. This restriction is in place until the audited FY26 financial results are officially announced.

Key Risks and Scrutiny

The company's recent financial performance, characterized by substantial losses and declining revenues, remains a primary risk factor. While this trading window closure is routine compliance, sustained poor financial results could invite further scrutiny. In September 2022, the stock exchange had previously sought clarification from the company regarding a notable price movement, highlighting earlier periods of increased attention.

Comparison with Peers

Diamines & Chemicals operates in the specialty chemicals sector alongside established players such as SRF Ltd., Gujarat Fluorochemicals Ltd., and Aarti Industries Ltd. However, recent financial data shows a stark contrast. While peers like SRF and Gujarat Fluorochemicals demonstrate strong financial health and growth, Diamines & Chemicals is struggling with significant losses and revenue contraction. This performance gap highlights the unique difficulties faced by Diamines & Chemicals compared to its stronger competitors.

Next Steps for Investors

Investors will be watching for the date of the Board Meeting to approve the FY26 audited results, the actual financial performance reported for FY26 and how it compares to market expectations, any forward-looking guidance or strategic plans announced, and progress on the conversion of outstanding warrants into equity shares.